Molecular targeting for treatment of human T-lymphotropic virus type 1 infection
Human T-cell lymphotropic virus type 1 (HTLV-1) infection is linked to adult T-cell leukemia-lymphoma (ATLL) and HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and several other disorders. ATLL occurs in approximately 5% of the 15–20 million people infected by HTLV-1 in the worl...
Main Authors: | Arash Soltani, Seyed Isaac Hashemy, Farnaz Zahedi Avval, Anvar Soleimani, Houshang Rafatpanah, Seyed Abdorahim Rezaee, Renate Griffith, Baratali Mashkani |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332218354817 |
Similar Items
-
Variant Human T-cell Lymphotropic Virus Type 1c and Adult T-cell Leukemia, Australia
by: Lloyd Einsiedel, et al.
Published: (2013-10-01) -
Leukemia / Lymphoma T of the adult HTLV1, a challenge for the clinic
by: María Elena Cabrera, et al.
Published: (2020-03-01) -
Lesões dermatológicas em pacientes infectados pelo vírus linfotrópico humano de células T do tipo 1 (HTLV-1) Dermatologic lesions in patients infected with the human T-cell lymphotropic vírus type 1 (HTLV-1)
by: Vandack Nobre, et al.
Published: (2005-02-01) -
HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina
by: Paula Benencio, et al.
Published: (2020-09-01) -
Exploration of mRNAs and miRNA classifiers for various ATLL cancer subtypes using machine learning
by: Afsaneh, E., et al.
Published: (2022)